These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 25000528)
1. In vitro palmitate treatment of myotubes from postmenopausal women leads to ceramide accumulation, inflammation and affected insulin signaling. Abildgaard J; Henstridge DC; Pedersen AT; Langley KG; Scheele C; Pedersen BK; Lindegaard B PLoS One; 2014; 9(7):e101555. PubMed ID: 25000528 [TBL] [Abstract][Full Text] [Related]
2. Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid. Sabin MA; Stewart CE; Crowne EC; Turner SJ; Hunt LP; Welsh GI; Grohmann MJ; Holly JM; Shield JP J Cell Physiol; 2007 Apr; 211(1):244-52. PubMed ID: 17219404 [TBL] [Abstract][Full Text] [Related]
4. Physical activity is associated with retained muscle metabolism in human myotubes challenged with palmitate. Green CJ; Bunprajun T; Pedersen BK; Scheele C J Physiol; 2013 Sep; 591(18):4621-35. PubMed ID: 23774280 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of lipin-1 induces insulin resistance by increasing intracellular ceramide accumulation in C2C12 myotubes. Huang S; Huang S; Wang X; Zhang Q; Liu J; Leng Y Int J Biol Sci; 2017; 13(1):1-12. PubMed ID: 28123341 [TBL] [Abstract][Full Text] [Related]
6. IRE1α and TRB3 do not contribute to the disruption of proximal insulin signaling caused by palmitate in C2C12 myotubes. Pierre N; Fernández-Verdejo R; Regnier P; Vanmechelen S; Demeulder B; Francaux M Cell Biol Int; 2016 Jan; 40(1):91-9. PubMed ID: 26337904 [TBL] [Abstract][Full Text] [Related]
7. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Chavez JA; Summers SA Arch Biochem Biophys; 2003 Nov; 419(2):101-9. PubMed ID: 14592453 [TBL] [Abstract][Full Text] [Related]
8. Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment. Frangioudakis G; Diakanastasis B; Liao BQ; Saville JT; Hoffman NJ; Mitchell TW; Schmitz-Peiffer C Diabetologia; 2013 Dec; 56(12):2697-701. PubMed ID: 23989724 [TBL] [Abstract][Full Text] [Related]
9. Insulin-stimulated Rac1-GTP binding is not impaired by palmitate treatment in L6 myotubes. Stierwalt HD; Ehrlicher SE; Bergman BC; Robinson MM; Newsom SA Physiol Rep; 2018 Dec; 6(24):e13956. PubMed ID: 30592185 [TBL] [Abstract][Full Text] [Related]
10. Lipid-induced insulin resistance is prevented in lean and obese myotubes by AICAR treatment. Bikman BT; Zheng D; Reed MA; Hickner RC; Houmard JA; Dohm GL Am J Physiol Regul Integr Comp Physiol; 2010 Jun; 298(6):R1692-9. PubMed ID: 20393162 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Turpin SM; Lancaster GI; Darby I; Febbraio MA; Watt MJ Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1341-50. PubMed ID: 16849630 [TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells. Taheripak G; Bakhtiyari S; Rajabibazl M; Pasalar P; Meshkani R Free Radic Biol Med; 2013 Dec; 65():1435-1446. PubMed ID: 24120971 [TBL] [Abstract][Full Text] [Related]
13. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. Perdomo G; Commerford SR; Richard AM; Adams SH; Corkey BE; O'Doherty RM; Brown NF J Biol Chem; 2004 Jun; 279(26):27177-86. PubMed ID: 15105415 [TBL] [Abstract][Full Text] [Related]
14. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064 [TBL] [Abstract][Full Text] [Related]
15. Protection from palmitate-induced mitochondrial DNA damage prevents from mitochondrial oxidative stress, mitochondrial dysfunction, apoptosis, and impaired insulin signaling in rat L6 skeletal muscle cells. Yuzefovych LV; Solodushko VA; Wilson GL; Rachek LI Endocrinology; 2012 Jan; 153(1):92-100. PubMed ID: 22128025 [TBL] [Abstract][Full Text] [Related]
16. The chemokine CXCL16 can rescue the defects in insulin signaling and sensitivity caused by palmitate in C2C12 myotubes. Bitsi S Cytokine; 2020 Sep; 133():155154. PubMed ID: 32535333 [TBL] [Abstract][Full Text] [Related]
17. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients. Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433 [TBL] [Abstract][Full Text] [Related]
18. Leucine decreases intramyocellular lipid deposition in an mTORC1-independent manner in palmitate-treated C2C12 myotubes. Wu H; Dridi S; Huang Y; Baum JI Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E152-E163. PubMed ID: 31770014 [TBL] [Abstract][Full Text] [Related]
19. Palmitate-induced PTP1B expression is mediated by ceramide-JNK and nuclear factor κB (NF-κB) activation. MohammadTaghvaei N; Taheripak G; Taghikhani M; Meshkani R Cell Signal; 2012 Oct; 24(10):1964-70. PubMed ID: 22580159 [TBL] [Abstract][Full Text] [Related]
20. Fenofibrate Reverses Palmitate Induced Impairment in Glucose Uptake in Skeletal Muscle Cells by Preventing Cytosolic Ceramide Accumulation. Bhattacharjee S; Das N; Mandala A; Mukhopadhyay S; Roy SS Cell Physiol Biochem; 2015; 37(4):1315-28. PubMed ID: 26488284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]